SCHEMBL24028877

SCHEMBL24028877

c1ccc(C(c2ccccc2)(c2ccccc2)c2ccc(-c3nc(-n4c5ccccc5c5ccccc54)cc(-n4c5ccccc5c5ccccc54)n3)cc2)cc1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.37
▸ ATM Q13315 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ TP53 P04637 3/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ ABCG2 Q9UNQ0 6/20 0.35
▸ NPSR1 Q6W5P4 3/20 0.35
▸ MAPT P10636 2/20 0.35
▸ MAPK1 P28482 2/20 0.35
▸ TSHR P16473 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ HPGD P15428 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ GBA1 P04062 1/20 0.33
▸ KIF11 P52732 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24028524 0.92 ABCG2 (0.41) HTTKDM4ETP53SMN1; SMN2MEN1
SCHEMBL24028706 0.92 MAPT (0.46) HTTKDM4ETP53SMN1; SMN2MEN1
SCHEMBL22549402 0.89 HTT (0.38) HTTKDM4EATML3MBTL1TP53
SCHEMBL24028718 0.88 HTT (0.33) HTTTP53SMN1; SMN2MEN1RAB9A
SCHEMBL24028876 0.87 PTGER4 (0.37) KDM4ETP53MEN1KMT2AABCG2
SCHEMBL24028276 0.86 TSHR (0.34) HTTTP53SMN1; SMN2MEN1RAB9A
SCHEMBL11892583 0.86 HTT (0.49) HTTKDM4EATML3MBTL1SMN1; SMN2
SCHEMBL11892574 0.86 HTT (0.51) HTTKDM4EATML3MBTL1SMN1; SMN2
SCHEMBL24028521 0.85 MAPT (0.38) HTTKDM4EATML3MBTL1MEN1
SCHEMBL23900281 0.85 ATM (0.39) HTTKDM4EATML3MBTL1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210359215-A1 COMPOUND AND LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2021-11-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210359215-A1 COMPOUND AND LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, SIRT1 HTT 645/4885KDM4E 988/4885ATM 1211/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback